Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Barrowcliffe

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Haemostasis|January 1, 1982
Preparation of a stable phospholipid reagent for coagulation assaysT W Barrowcliffe, J Stocks, E Gray
Lancet (London, England)|April 1, 1974
Letter: Von Willebrand factor and factor-viii-related antigenP Stableforth, T W Barrowcliffe, K Dormandy
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Discrepancies in potency assessment of recombinant FVIII concentratesT W Barrowcliffe, S Raut, A R Hubbard
British Medical Bulletin|May 1, 1978
Antithrombin III and heparinT W Barrowcliffe, E A Johnson, D Thomas
Progress in Clinical and Biological Research|January 1, 1984
Effect of phospholipid on factor VIII inactivationT W Barrowcliffe, G Kemball-Cook, E Gray
Thrombosis Research|July 15, 1982
Studies of anti-Xa activity in human plasma. II: The role of lipoproteinsT W Barrowcliffe, C A Eggleton, J Stocks
Thrombosis and Haemostasis|July 4, 2001
A collaborative study to establish the 6th International Standard for factor VIII concentrateS Raut, A B Heath, T W Barrowcliffe
Vox Sanguinis|November 1, 1973
Small scale preparation and clinical use of factor IX-prothrombin complexT W Barrowcliffe, P Stableforth, K M Dormandy
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Standards and monitoring treatmentT W Barrowcliffe, A R Hubbard, S Kitchen
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
Overcoming factor VIII inhibitors: a possible new approachT W Barrowcliffe, G Kemball-Cook, E Gray
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Haemostasis|January 1, 1982
Preparation of a stable phospholipid reagent for coagulation assaysT W Barrowcliffe, J Stocks, E Gray
Lancet (London, England)|April 1, 1974
Letter: Von Willebrand factor and factor-viii-related antigenP Stableforth, T W Barrowcliffe, K Dormandy
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Discrepancies in potency assessment of recombinant FVIII concentratesT W Barrowcliffe, S Raut, A R Hubbard
British Medical Bulletin|May 1, 1978
Antithrombin III and heparinT W Barrowcliffe, E A Johnson, D Thomas
Progress in Clinical and Biological Research|January 1, 1984
Effect of phospholipid on factor VIII inactivationT W Barrowcliffe, G Kemball-Cook, E Gray
Thrombosis Research|July 15, 1982
Studies of anti-Xa activity in human plasma. II: The role of lipoproteinsT W Barrowcliffe, C A Eggleton, J Stocks
Thrombosis and Haemostasis|July 4, 2001
A collaborative study to establish the 6th International Standard for factor VIII concentrateS Raut, A B Heath, T W Barrowcliffe
Vox Sanguinis|November 1, 1973
Small scale preparation and clinical use of factor IX-prothrombin complexT W Barrowcliffe, P Stableforth, K M Dormandy
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Standards and monitoring treatmentT W Barrowcliffe, A R Hubbard, S Kitchen
Scandinavian Journal of Haematology. Supplementum|January 1, 1984
Overcoming factor VIII inhibitors: a possible new approachT W Barrowcliffe, G Kemball-Cook, E Gray
Pageof 16